Global Leukotriene Inhibitors Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2030

Table of Contents

1 Market Overview
    1.1 Leukotriene Inhibitors Introduction
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Leukotriene Inhibitors Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Montelukast
        1.3.3 Zafirlukast
        1.3.4 Proust
        1.3.5 Other
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Leukotriene Inhibitors Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Asthma
        1.4.3 COPD
        1.4.4 Allergic Rhinitis
        1.4.5 Other
    1.5 Global Leukotriene Inhibitors Market Size & Forecast
        1.5.1 Global Leukotriene Inhibitors Consumption Value (2019 & 2022 & 2030)
        1.5.2 Global Leukotriene Inhibitors Sales Quantity (2019-2030)
        1.5.3 Global Leukotriene Inhibitors Average Price (2019-2030) 
2 Manufacturers Profiles
    2.1 Mallinckrodt plc
        2.1.1 Mallinckrodt plc Details
        2.1.2 Mallinckrodt plc Major Business
        2.1.3 Mallinckrodt plc Leukotriene Inhibitors Product and Services
        2.1.4 Mallinckrodt plc Leukotriene Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022)
        2.1.5 Mallinckrodt plc Recent Developments/Updates
    2.2 Sun Pharmaceutical Industries Ltd
        2.2.1 Sun Pharmaceutical Industries Ltd Details
        2.2.2 Sun Pharmaceutical Industries Ltd Major Business
        2.2.3 Sun Pharmaceutical Industries Ltd Leukotriene Inhibitors Product and Services
        2.2.4 Sun Pharmaceutical Industries Ltd Leukotriene Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022)
        2.2.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates
    2.3 Novartis AG
        2.3.1 Novartis AG Details
        2.3.2 Novartis AG Major Business
        2.3.3 Novartis AG Leukotriene Inhibitors Product and Services
        2.3.4 Novartis AG Leukotriene Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022)
        2.3.5 Novartis AG Recent Developments/Updates
    2.4 Endo Pharmaceuticals plc
        2.4.1 Endo Pharmaceuticals plc Details
        2.4.2 Endo Pharmaceuticals plc Major Business
        2.4.3 Endo Pharmaceuticals plc Leukotriene Inhibitors Product and Services
        2.4.4 Endo Pharmaceuticals plc Leukotriene Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022)
        2.4.5 Endo Pharmaceuticals plc Recent Developments/Updates
    2.5 Zydus Cadila
        2.5.1 Zydus Cadila Details
        2.5.2 Zydus Cadila Major Business
        2.5.3 Zydus Cadila Leukotriene Inhibitors Product and Services
        2.5.4 Zydus Cadila Leukotriene Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022)
        2.5.5 Zydus Cadila Recent Developments/Updates
    2.6 Mylan NV
        2.6.1 Mylan NV Details
        2.6.2 Mylan NV Major Business
        2.6.3 Mylan NV Leukotriene Inhibitors Product and Services
        2.6.4 Mylan NV Leukotriene Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022)
        2.6.5 Mylan NV Recent Developments/Updates
    2.7 Mayne Pharma Group Limited
        2.7.1 Mayne Pharma Group Limited Details
        2.7.2 Mayne Pharma Group Limited Major Business
        2.7.3 Mayne Pharma Group Limited Leukotriene Inhibitors Product and Services
        2.7.4 Mayne Pharma Group Limited Leukotriene Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022)
        2.7.5 Mayne Pharma Group Limited Recent Developments/Updates
    2.8 Teva Pharmaceutical Industries Ltd
        2.8.1 Teva Pharmaceutical Industries Ltd Details
        2.8.2 Teva Pharmaceutical Industries Ltd Major Business
        2.8.3 Teva Pharmaceutical Industries Ltd Leukotriene Inhibitors Product and Services
        2.8.4 Teva Pharmaceutical Industries Ltd Leukotriene Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022)
        2.8.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
    2.9 Amneal Pharmaceutical Inc
        2.9.1 Amneal Pharmaceutical Inc Details
        2.9.2 Amneal Pharmaceutical Inc Major Business
        2.9.3 Amneal Pharmaceutical Inc Leukotriene Inhibitors Product and Services
        2.9.4 Amneal Pharmaceutical Inc Leukotriene Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022)
        2.9.5 Amneal Pharmaceutical Inc Recent Developments/Updates
    2.10 Avet Pharmaceuticals Inc
        2.10.1 Avet Pharmaceuticals Inc Details
        2.10.2 Avet Pharmaceuticals Inc Major Business
        2.10.3 Avet Pharmaceuticals Inc Leukotriene Inhibitors Product and Services
        2.10.4 Avet Pharmaceuticals Inc Leukotriene Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022)
        2.10.5 Avet Pharmaceuticals Inc Recent Developments/Updates
    2.11 Aurobindo Pharma
        2.11.1 Aurobindo Pharma Details
        2.11.2 Aurobindo Pharma Major Business
        2.11.3 Aurobindo Pharma Leukotriene Inhibitors Product and Services
        2.11.4 Aurobindo Pharma Leukotriene Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022)
        2.11.5 Aurobindo Pharma Recent Developments/Updates
    2.12 GSK plc
        2.12.1 GSK plc Details
        2.12.2 GSK plc Major Business
        2.12.3 GSK plc Leukotriene Inhibitors Product and Services
        2.12.4 GSK plc Leukotriene Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022)
        2.12.5 GSK plc Recent Developments/Updates
    2.13 Almirall, SA
        2.13.1 Almirall, SA Details
        2.13.2 Almirall, SA Major Business
        2.13.3 Almirall, SA Leukotriene Inhibitors Product and Services
        2.13.4 Almirall, SA Leukotriene Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022)
        2.13.5 Almirall, SA Recent Developments/Updates
    2.14 Merck & Co., Inc
        2.14.1 Merck & Co., Inc Details
        2.14.2 Merck & Co., Inc Major Business
        2.14.3 Merck & Co., Inc Leukotriene Inhibitors Product and Services
        2.14.4 Merck & Co., Inc Leukotriene Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022)
        2.14.5 Merck & Co., Inc Recent Developments/Updates
    2.15 Bausch Health
        2.15.1 Bausch Health Details
        2.15.2 Bausch Health Major Business
        2.15.3 Bausch Health Leukotriene Inhibitors Product and Services
        2.15.4 Bausch Health Leukotriene Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022)
        2.15.5 Bausch Health Recent Developments/Updates
    2.16 Sandoz International GmbH
        2.16.1 Sandoz International GmbH Details
        2.16.2 Sandoz International GmbH Major Business
        2.16.3 Sandoz International GmbH Leukotriene Inhibitors Product and Services
        2.16.4 Sandoz International GmbH Leukotriene Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022)
        2.16.5 Sandoz International GmbH Recent Developments/Updates
    2.17 Pfizer Inc
        2.17.1 Pfizer Inc Details
        2.17.2 Pfizer Inc Major Business
        2.17.3 Pfizer Inc Leukotriene Inhibitors Product and Services
        2.17.4 Pfizer Inc Leukotriene Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022)
        2.17.5 Pfizer Inc Recent Developments/Updates
    2.18 AstraZeneca
        2.18.1 AstraZeneca Details
        2.18.2 AstraZeneca Major Business
        2.18.3 AstraZeneca Leukotriene Inhibitors Product and Services
        2.18.4 AstraZeneca Leukotriene Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022)
        2.18.5 AstraZeneca Recent Developments/Updates
    2.19 Sanofi
        2.19.1 Sanofi Details
        2.19.2 Sanofi Major Business
        2.19.3 Sanofi Leukotriene Inhibitors Product and Services
        2.19.4 Sanofi Leukotriene Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022)
        2.19.5 Sanofi Recent Developments/Updates
    2.20 Bayer AG
        2.20.1 Bayer AG Details
        2.20.2 Bayer AG Major Business
        2.20.3 Bayer AG Leukotriene Inhibitors Product and Services
        2.20.4 Bayer AG Leukotriene Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022)
        2.20.5 Bayer AG Recent Developments/Updates
    2.21 McKesson Corporation
        2.21.1 McKesson Corporation Details
        2.21.2 McKesson Corporation Major Business
        2.21.3 McKesson Corporation Leukotriene Inhibitors Product and Services
        2.21.4 McKesson Corporation Leukotriene Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022)
        2.21.5 McKesson Corporation Recent Developments/Updates
3 Competitive Environment: Leukotriene Inhibitors by Manufacturer
    3.1 Global Leukotriene Inhibitors Sales Quantity by Manufacturer (2019-2022)
    3.2 Global Leukotriene Inhibitors Revenue by Manufacturer (2019-2022)
    3.3 Global Leukotriene Inhibitors Average Price by Manufacturer (2019-2022)
    3.4 Market Share Analysis (2021)
        3.4.1 Producer Shipments of Leukotriene Inhibitors by Manufacturer Revenue ($MM) and Market Share (%): 2021
        3.4.2 Top 3 Leukotriene Inhibitors Manufacturer Market Share in 2021
        3.4.2 Top 6 Leukotriene Inhibitors Manufacturer Market Share in 2021
    3.5 Leukotriene Inhibitors Market: Overall Company Footprint Analysis
        3.5.1 Leukotriene Inhibitors Market: Region Footprint
        3.5.2 Leukotriene Inhibitors Market: Company Product Type Footprint
        3.5.3 Leukotriene Inhibitors Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
    4.1 Global Leukotriene Inhibitors Market Size by Region
        4.1.1 Global Leukotriene Inhibitors Sales Quantity by Region (2019-2030)
        4.1.2 Global Leukotriene Inhibitors Consumption Value by Region (2019-2030)
        4.1.3 Global Leukotriene Inhibitors Average Price by Region (2019-2030)
    4.2 North America Leukotriene Inhibitors Consumption Value (2019-2030)
    4.3 Europe Leukotriene Inhibitors Consumption Value (2019-2030)
    4.4 Asia-Pacific Leukotriene Inhibitors Consumption Value (2019-2030)
    4.5 South America Leukotriene Inhibitors Consumption Value (2019-2030)
    4.6 Middle East and Africa Leukotriene Inhibitors Consumption Value (2019-2030)
5 Market Segment by Type
    5.1 Global Leukotriene Inhibitors Sales Quantity by Type (2019-2030)
    5.2 Global Leukotriene Inhibitors Consumption Value by Type (2019-2030)
    5.3 Global Leukotriene Inhibitors Average Price by Type (2019-2030)
6 Market Segment by Application
    6.1 Global Leukotriene Inhibitors Sales Quantity by Application (2019-2030)
    6.2 Global Leukotriene Inhibitors Consumption Value by Application (2019-2030)
    6.3 Global Leukotriene Inhibitors Average Price by Application (2019-2030)
7 North America
    7.1 North America Leukotriene Inhibitors Sales Quantity by Type (2019-2030)
    7.2 North America Leukotriene Inhibitors Sales Quantity by Application (2019-2030)
    7.3 North America Leukotriene Inhibitors Market Size by Country
        7.3.1 North America Leukotriene Inhibitors Sales Quantity by Country (2019-2030)
        7.3.2 North America Leukotriene Inhibitors Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
    8.1 Europe Leukotriene Inhibitors Sales Quantity by Type (2019-2030)
    8.2 Europe Leukotriene Inhibitors Sales Quantity by Application (2019-2030)
    8.3 Europe Leukotriene Inhibitors Market Size by Country
        8.3.1 Europe Leukotriene Inhibitors Sales Quantity by Country (2019-2030)
        8.3.2 Europe Leukotriene Inhibitors Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
    9.1 Asia-Pacific Leukotriene Inhibitors Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Leukotriene Inhibitors Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Leukotriene Inhibitors Market Size by Region
        9.3.1 Asia-Pacific Leukotriene Inhibitors Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Leukotriene Inhibitors Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
    10.1 South America Leukotriene Inhibitors Sales Quantity by Type (2019-2030)
    10.2 South America Leukotriene Inhibitors Sales Quantity by Application (2019-2030)
    10.3 South America Leukotriene Inhibitors Market Size by Country
        10.3.1 South America Leukotriene Inhibitors Sales Quantity by Country (2019-2030)
        10.3.2 South America Leukotriene Inhibitors Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
    11.1 Middle East & Africa Leukotriene Inhibitors Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Leukotriene Inhibitors Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Leukotriene Inhibitors Market Size by Country
        11.3.1 Middle East & Africa Leukotriene Inhibitors Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Leukotriene Inhibitors Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
    12.1 Leukotriene Inhibitors Market Drivers
    12.2 Leukotriene Inhibitors Market Restraints
    12.3 Leukotriene Inhibitors Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
    13.1 Raw Material of Leukotriene Inhibitors and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Leukotriene Inhibitors
    13.3 Leukotriene Inhibitors Production Process
    13.4 Leukotriene Inhibitors Industrial Chain
14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Leukotriene Inhibitors Typical Distributors
    14.3 Leukotriene Inhibitors Typical Customers
15 Research Findings and Conclusion
16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer